Navegação Ciências da Saúde por Assunto "Dasatinib"

Resultados 1-1 de 1

    • What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials? 

      Bosi, Guilherme Rasia; Fogliatto, Laura Maria; Costa, Tito Emílio Vanelli; Grokoski, Kamila Castro; Pereira, Mariana Pinto; Bugs, Nathan; Kalil, Marco Antônio Baptista; Fraga, Christina Garcia da Silva; Daudt, Liane Esteves; Silla, Lucia Mariano da Rocha (2019) [Artigo de periódico]
      Objective: To assess clinical outcomes of intolerant, relapsed or refractory patients who could not be treated with new tyrosine kinase inhibitors or experimental therapies. Methods: A retrospective cohort of 90 chronic ...